Vitamin D receptor regulates TNF-mediated arthritis

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 1122-1129

  Zwerina, Karin ^a   Baum, Wolfgang ^a   Axmann, Roland ^a   Heiland, Gisela Ruiz ^a   Distler, Jörg H ^a   Smolen, Josef ^b   Hayer, Silvia ^b   Zwerina, Jochen ^a,c   Schett, Georg ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c AUVA Soziale Unfallversicherung   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE EROSION; CELL DIFFERENTIATION; CHRONIC ARTHRITIS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVATION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNOVITIS; VITAMIN D DEFICIENCY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE RESORPTION; CARTILAGE, ARTICULAR; CELLS, CULTURED; CYTOKINES; MACROPHAGES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OSTEOCLASTS; PROTEOGLYCANS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955861129     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.142331     Document Type: Article

References (28)

1. Scott D L, Steer S. The course of established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007 ; 21 : 943-67. (Pubitemid 47377808) (Pubitemid 47377808)
2. McInnes I B, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. N at Rev Immunol 2007 ; 7 : 429-42. (Pubitemid 46834849) (Pubitemid 46834849)
3. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003 ; 2 : 473-88. (Pubitemid 37361728) (Pubitemid 37361728)
4. Holick M F. Vitamin D deficiency. N Engl J Med 2007 ;3 57 : 266-81.
5. Deluca H F, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001 ; 15 : 2579-85. (Pubitemid 33131084) (Pubitemid 33131084)
6. Mathieu C, Laureys J, Sobis H, et al. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992 ; 41 : 1491-5.
7. Cantorna M T, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996 ; 93 : 7861-4. (Pubitemid 26277129) (Pubitemid 26277129)
8. Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001 ; 358 : 1500-3. (Pubitemid 33055701) (Pubitemid 33055701)
9. Munger K L, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006 ; 296 : 2832-8. (Pubitemid 44969183) (Pubitemid 44969183)
10. Patel S, Farragher T, Berry J, et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007 ; 56 : 2143-9. (Pubitemid 47173561) (Pubitemid 47173561)
11. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991 ; 10 : 4025-31. (Pubitemid 21905432) (Pubitemid 21905432)
12. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997 ; 16 : 391-6. (Pubitemid 27323308) (Pubitemid 27323308)
13. Zwerina J, Hayer S, Tohidast-Akrad M, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004 ; 50 : 277-90. (Pubitemid 38084313) (Pubitemid 38084313)
14. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987 ; 2 : 595-610.
15. Zwerina J, Redlich K, Polzer K, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 2007 ; 104 : 11742-7. (Pubitemid 47175083) (Pubitemid 47175083)
16. Leslie WD, Miller N, Rogala L, et al. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 2008 ; 103 : 1451-9. (Pubitemid 351813899) (Pubitemid 351813899)
17. Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008 ; 47 : 920-3. (Pubitemid 351796385) (Pubitemid 351796385)
18. Merlino L A, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004 ; 50 : 72-7. (Pubitemid 38084289) (Pubitemid 38084289)
19. Tetlow LC, Smith SJ, Mawer EB, et al. Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes. Ann Rheum Dis 1999 ; 58 : 118-21. (Pubitemid 29116313) (Pubitemid 29116313)
20. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25- dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984 ; 74 : 1451-5. (Pubitemid 15200239) (Pubitemid 15200239)
21. Colin EM, Asmawidjaja PS, van Hamburg JP, et al. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010 ; 62 : 132-42.
22. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998 ; 128 : 68-72. (Pubitemid 28087178) (Pubitemid 28087178)
23. Larsson P, Mattsson L, Klareskog L, et al. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 1998 ; 114 : 277-83. (Pubitemid 28505730) (Pubitemid 28505730)
24. Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007 ; 179 : 1634-47.
25. Lemire JM, Adams JS, Sakai R, et al. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984 ; 74 : 657-61. (Pubitemid 14054016) (Pubitemid 14054016)
26. Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006 ; 36 : 361-70. (Pubitemid 43257459) (Pubitemid 43257459)
27. Stoffels K, Overbergh L, Giulietti A, et al. Immune regulation of 25-hydroxyvitamin- D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 2006 ; 21 : 37-47. (Pubitemid 43023225) (Pubitemid 43023225)
28. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007 ; 66 : 1137-42. (Pubitemid 47309727) (Pubitemid 47309727)